Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma

Accumulating evidence indicates that the reliable gene signature may serve as an independent prognosis factor for lung adenocarcinoma (LUAD) diagnosis. Here, we sought to identify a risk score signature for survival prediction of LUAD patients. In the Gene Expression Omnibus (GEO) database, GSE18842...

Full description

Bibliographic Details
Main Authors: Zhaodong Li, Fangyuan Qi, Fan Li
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/22/8479
_version_ 1797548201241214976
author Zhaodong Li
Fangyuan Qi
Fan Li
author_facet Zhaodong Li
Fangyuan Qi
Fan Li
author_sort Zhaodong Li
collection DOAJ
description Accumulating evidence indicates that the reliable gene signature may serve as an independent prognosis factor for lung adenocarcinoma (LUAD) diagnosis. Here, we sought to identify a risk score signature for survival prediction of LUAD patients. In the Gene Expression Omnibus (GEO) database, GSE18842, GSE75037, GSE101929, and GSE19188 mRNA expression profiles were downloaded to screen differentially expressed genes (DEGs), which were used to establish a protein-protein interaction network and perform clustering module analysis. Univariate and multivariate proportional hazards regression analyses were applied to develop and validate the gene signature based on the TCGA dataset. The signature genes were then verified on GEPIA, Oncomine, and HPA platforms. Expression levels of corresponding genes were also measured by qRT-PCR and Western blotting in HBE, A549, and PC-9 cell lines. The prognostic signature based on eight genes (<i>TTK</i>, <i>HMMR</i>, <i>ASPM</i>, <i>CDCA8</i>, <i>KIF2C</i>, <i>CCNA2</i>, <i>CCNB2</i>, and <i>MKI67</i>) was established, which was independent of other clinical factors. The risk model offered better discrimination between risk groups, and patients with high-risk scores tended to have poor survival rate at 1-, 3- and 5-year follow-up. The model also presented better survival prediction in cancer-specific cohorts of age, gender, clinical stage III/IV, primary tumor 1/2, and lymph node metastasis 1/2. The signature genes, moreover, were highly expressed in A549 and PC-9 cells. In conclusion, the risk score signature could be used for prognostic estimation and as an independent risk factor for survival prediction in patients with LUAD.
first_indexed 2024-03-10T14:56:02Z
format Article
id doaj.art-9a5927343e1d41b4afbc0f6978f6f632
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T14:56:02Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-9a5927343e1d41b4afbc0f6978f6f6322023-11-20T20:34:02ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-012122847910.3390/ijms21228479Establishment of a Gene Signature to Predict Prognosis for Patients with Lung AdenocarcinomaZhaodong Li0Fangyuan Qi1Fan Li2The Key Laboratory of Zoonosis, Department of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130021, ChinaThe Key Laboratory of Zoonosis, Department of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130021, ChinaThe Key Laboratory of Zoonosis, Department of Pathogenobiology, College of Basic Medicine, Jilin University, Changchun 130021, ChinaAccumulating evidence indicates that the reliable gene signature may serve as an independent prognosis factor for lung adenocarcinoma (LUAD) diagnosis. Here, we sought to identify a risk score signature for survival prediction of LUAD patients. In the Gene Expression Omnibus (GEO) database, GSE18842, GSE75037, GSE101929, and GSE19188 mRNA expression profiles were downloaded to screen differentially expressed genes (DEGs), which were used to establish a protein-protein interaction network and perform clustering module analysis. Univariate and multivariate proportional hazards regression analyses were applied to develop and validate the gene signature based on the TCGA dataset. The signature genes were then verified on GEPIA, Oncomine, and HPA platforms. Expression levels of corresponding genes were also measured by qRT-PCR and Western blotting in HBE, A549, and PC-9 cell lines. The prognostic signature based on eight genes (<i>TTK</i>, <i>HMMR</i>, <i>ASPM</i>, <i>CDCA8</i>, <i>KIF2C</i>, <i>CCNA2</i>, <i>CCNB2</i>, and <i>MKI67</i>) was established, which was independent of other clinical factors. The risk model offered better discrimination between risk groups, and patients with high-risk scores tended to have poor survival rate at 1-, 3- and 5-year follow-up. The model also presented better survival prediction in cancer-specific cohorts of age, gender, clinical stage III/IV, primary tumor 1/2, and lymph node metastasis 1/2. The signature genes, moreover, were highly expressed in A549 and PC-9 cells. In conclusion, the risk score signature could be used for prognostic estimation and as an independent risk factor for survival prediction in patients with LUAD.https://www.mdpi.com/1422-0067/21/22/8479lung adenocarcinomagene signatureoverall survivalprognosisbioinformatic analysis
spellingShingle Zhaodong Li
Fangyuan Qi
Fan Li
Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
International Journal of Molecular Sciences
lung adenocarcinoma
gene signature
overall survival
prognosis
bioinformatic analysis
title Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
title_full Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
title_fullStr Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
title_full_unstemmed Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
title_short Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
title_sort establishment of a gene signature to predict prognosis for patients with lung adenocarcinoma
topic lung adenocarcinoma
gene signature
overall survival
prognosis
bioinformatic analysis
url https://www.mdpi.com/1422-0067/21/22/8479
work_keys_str_mv AT zhaodongli establishmentofagenesignaturetopredictprognosisforpatientswithlungadenocarcinoma
AT fangyuanqi establishmentofagenesignaturetopredictprognosisforpatientswithlungadenocarcinoma
AT fanli establishmentofagenesignaturetopredictprognosisforpatientswithlungadenocarcinoma